Tachmed aims to transform access to healthcare through technology. The company’s CEO, Paul Christie, tells us how.
What is the driving force behind Tachmed? What motivated you to work on the transformation of digital diagnostic technology?
The idea of Tachmed was born during my private equity career. I was with a team that was running a fund in Africa and as part of our impact activities we were reviewing local community health care. It quickly became clear that health data in World Health Organization (WHO) reports was two or three years out of date.
These seemingly outdated community health epidemiology reports may have seriously distorted any policy making and action on the ground. It seemed to me that advances in digital mobile technology were available to positively break this outdated approach. This made me wonder why we can’t have diagnostics that leverage advances in materials, digital technology and telemedicine that provide real-time data to clinicians and other organizations.
I think it’s criminal that in some civilized societies there are people who don’t have access to health services. Health shouldn’t be reserved for the wealthiest of people and then trickle down to the masses, and no one should worry about not being able to get a doctor to see their children. Tachmed technology will change that.
What do you think are the key lessons that the industry, along with the world’s leading companies, can learn from the COVID-19 pandemic?
With the rapid spread of COVID-19 in 2020, consumers have certainly become more conscious of their own health and the concept of at-home testing. Similarly, global health security and surveillance is now being taken much more seriously. While many lessons have been learned, I would say the most important one has to relate to the technology that is now available to prevent COVID-19 from recurring.
The development of advanced materials, graphene biosensors and nanotechnology, and clinicians realizing the importance of electrochemistry in measuring the body really cannot be underestimated. This technology will continue to transform the way consumers manage their own health, providing real-time data to inform government decision-making.
It will fundamentally change the way global health systems work and how people relate to their health.
Can you tell us how digital diagnostic technology for the home has the potential to transform healthcare on a global scale?
We’ve already seen how Apple Watches and FitBits have impacted people’s awareness of their own health, and home digital diagnostic technology is catering to the growing demand for tools that consumers can use in their own homes.
These tools can be widely used for a number of different diagnoses and I believe this will really change the way people behave and how they relate to their own health and ease the pressure on clinicians and medical professionals. Health care will focus more on prevention, better health quality and not only on curative measures.
What can Tachmed offer the healthtech industry? How is the company’s approach different?
At Tachmed, we bring together breathtakingly ambitious scientists with world-class engineers from across the spectrum and not just life sciences to deliver new products that are transformative and game-changing.
The Tachmed device provides instant data on a person’s health status. The AI can then make decisions about the actions needed and calculate what behavior changes or therapies are needed to improve that person’s health. This technology will drive a more efficient and cost-effective way of working and will finally make healthcare more accessible.